ArticleJournal of clinical medicine2023

Predictive Factors of Early Response to Dupilumab in Patients with Moderate-to-Severe Atopic Dermatitis.

Silvia Ferrucci et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.